发明名称 |
TETRACYCLINE-REGULATED GENE EXPRESSION IN HSV-1 VECTORS |
摘要 |
The present invention is directed to HSV-1 vectors which rely on the tetracycline repressor and operator as a means for regulating expression. The vectors utilize VP-16 responsive promoters of HSV to control expression of the tetracycline repressor. The vectors are of particular interest as vehicles for recombinantly expressing genes in vivo. |
申请公布号 |
US2015337319(A1) |
申请公布日期 |
2015.11.26 |
申请号 |
US201514823669 |
申请日期 |
2015.08.11 |
申请人 |
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. |
发明人 |
YAO Feng |
分类号 |
C12N15/63;C12N7/00;C07K14/005;C12N15/86 |
主分类号 |
C12N15/63 |
代理机构 |
|
代理人 |
|
主权项 |
1. An HSV-1 viral vector having a genomic DNA construct comprising:
a) at least two tetR nucleotide sequences coding for the tetracycline repressor, wherein the expression of each tetR nucleotide sequence is under the control of a VP-16 responsive immediate early promoter selected from the group consisting of: the ICP-0 immediate early promoter of HSV-1; the ICP-4 immediate early promoter of HSV-1; LAP2/ICP0; and LAP2/ICP4; b) an additional promoter wherein additional promoter includes a TATA element; c) a tetracycline operator sequence positioned between 6 and 24 nucleotides 3′ to said TATA element; and d) a structural sequence whose expression is regulated by said additional promoter. |
地址 |
Boston MA US |